Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2653
-0.0013-0.49%
Post-market: 0.27550.0102+3.84%19:34 EDT
Volume:474.18K
Turnover:128.79K
Market Cap:68.24M
PE:-0.88
High:0.2840
Open:0.2840
Low:0.2608
Close:0.2666
Loading ...

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
21 Apr

Adaptimmune Therapeutics Plc - CFO Gavin Wood's Termination Date Extended to August 31, 2025 - SEC Filing

THOMSON REUTERS
·
15 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

Adaptimmune downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
12 Apr

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading

MT Newswires Live
·
11 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Adaptimmune Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Adaptimmune Therapeutics Plc : H.c. Wainwright Cuts Target Price to $3 From $3.5

THOMSON REUTERS
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live
·
28 Mar

Barclays Remains a Sell on Adaptimmune Therapeutics (ADAP)

TIPRANKS
·
27 Mar

Adaptimmune Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
26 Mar

Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $1.75 From $3

THOMSON REUTERS
·
26 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

Adaptimmune Therapeutics (ADAP) Gets a Buy from Scotiabank

TIPRANKS
·
25 Mar

ADAP 4Q24 Earnings Review: EPS Miss on 1x Restructuring/Impairment Costs; Potential Capital Raise Adds Risk to the Story

Zacks Small Cap Research
·
25 Mar

BRIEF-Adaptimmune Therapeutics PLC - Enters Amendment To Loan And Security Agreement - SEC Filing

Reuters
·
25 Mar

Adaptimmune Therapeutics Plc - to Make $25 Mln Loan Prepayment - SEC Filing

THOMSON REUTERS
·
25 Mar

Adaptimmune Therapeutics Plc : Scotiabank Cuts Target Price to $1.4 From $3.15

THOMSON REUTERS
·
21 Mar